These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10549825)

  • 1. The L392V mutation of presenilin 1 associated with autosomal dominant early-onset Alzheimer's disease alters the secondary structure of the hydrophilic loop.
    Gantier R; Dumanchin C; Campion D; Loutelier C; Lange C; Gagnon J; Davoust D; Frébourg T; Toma F
    Neuroreport; 1999 Sep; 10(14):3071-4. PubMed ID: 10549825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 beta.
    Gantier R; Gilbert D; Dumanchin C; Campion D; Davoust D; Toma F; Frébourg T
    Neurosci Lett; 2000 Apr; 283(3):217-20. PubMed ID: 10754226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia.
    Arango D; Cruts M; Torres O; Backhovens H; Serrano ML; Villareal E; Montañes P; Matallana D; Cano C; Van Broeckhoven C; Jacquier M
    Am J Med Genet; 2001 Oct; 103(2):138-43. PubMed ID: 11568920
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bagyinszky E; Lee HM; Van Giau V; Koh SB; Jeong JH; An SSA; Kim S
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30200536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer's disease.
    Somavarapu AK; Kepp KP
    J Neurochem; 2016 Apr; 137(1):101-11. PubMed ID: 26756738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.
    Campion D; Dumanchin C; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Anterion C; Michon A; Martin C; Charbonnier F; Raux G; Camuzat A; Penet C; Mesnage V; Martinez M; Clerget-Darpoux F; Brice A; Frebourg T
    Am J Hum Genet; 1999 Sep; 65(3):664-70. PubMed ID: 10441572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland.
    Zekanowski C; Styczyńska M; Pepłońska B; Gabryelewicz T; Religa D; Ilkowski J; Kijanowska-Haładyna B; Kotapka-Minc S; Mikkelsen S; Pfeffer A; Barczak A; Łuczywek E; Wasiak B; Chodakowska-Zebrowska M; Gustaw K; Łaczkowski J; Sobów T; Kuźnicki J; Barcikowska M
    Exp Neurol; 2003 Dec; 184(2):991-6. PubMed ID: 14769392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presenilins and Alzheimer's disease.
    Hutton M; Hardy J
    Hum Mol Genet; 1997; 6(10):1639-46. PubMed ID: 9300655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain.
    Lleó A; Blesa R; Queralt R; Ezquerra M; Molinuevo JL; Peña-Casanova J; Rojo A; Oliva R
    Arch Neurol; 2002 Nov; 59(11):1759-63. PubMed ID: 12433263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.
    Raux G; Guyant-Maréchal L; Martin C; Bou J; Penet C; Brice A; Hannequin D; Frebourg T; Campion D
    J Med Genet; 2005 Oct; 42(10):793-5. PubMed ID: 16033913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion.
    De Jonghe C; Cruts M; Rogaeva EA; Tysoe C; Singleton A; Vanderstichele H; Meschino W; Dermaut B; Vanderhoeven I; Backhovens H; Vanmechelen E; Morris CM; Hardy J; Rubinsztein DC; St George-Hyslop PH; Van Broeckhoven C
    Hum Mol Genet; 1999 Aug; 8(8):1529-40. PubMed ID: 10401002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
    Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
    Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances.
    Queralt R; Ezquerra M; Lleó A; Castellví M; Gelpí J; Ferrer I; Acarín N; Pasarín L; Blesa R; Oliva R
    J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):266-9. PubMed ID: 11796781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical phenotype of G206D mutation in the presenilin 1 gene in pathologically confirmed familial Alzheimer's disease.
    Wu YY; Cheng IH; Lee CC; Chiu MJ; Lee MJ; Chen TF; Hsu JL
    J Alzheimers Dis; 2011; 25(1):145-50. PubMed ID: 21335660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes.
    Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Nordberg A; Viitanen M; Lannfelt L; Graff C
    Neurobiol Aging; 2019 Oct; 82():40-47. PubMed ID: 31386938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic counseling and testing for families with Alzheimer's disease].
    Kowalska A
    Neurol Neurochir Pol; 2004; 38(6):495-501. PubMed ID: 15654674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease.
    Liu CY; Ohki Y; Tomita T; Osawa S; Reed BR; Jagust W; Van Berlo V; Jin LW; Chui HC; Coppola G; Ringman JM
    J Alzheimers Dis; 2017; 58(4):1035-1041. PubMed ID: 28550247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutations and repeated findings of mutations in familial Alzheimer disease.
    Finckh U; Kuschel C; Anagnostouli M; Patsouris E; Pantes GV; Gatzonis S; Kapaki E; Davaki P; Lamszus K; Stavrou D; Gal A
    Neurogenetics; 2005 May; 6(2):85-9. PubMed ID: 15776278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.
    Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S
    J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.